Meeting
2016 Gastrointestinal Cancers Symposium
Long-term responders to palliative chemotherapy for advanced biliary tract cancer.
Authors
Mark Doherty
Department of Medical Oncology, University College Hospital Galway, Galway, Ireland
Mark Doherty , Mairead G McNamara , Priya Aneja , Anne M. Horgan , Raymond Woo-Jun Jang , Neesha C. Dhani , David W. Hedley , Jennifer J. Knox
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 391)
DOI
10.1200/jco.2016.34.4_suppl.391
Abstract #
391
Poster Bd #
K7
Abstract Disclosures
Similar Posters
Poster
2014 Gastrointestinal Cancers Symposium
Prognostic factors in advanced biliary tract cancer treated with first-line chemotherapy with cisplatin and gemcitabine.
First Author: Renata D'Alpino Peixoto
Poster
2022 ASCO Annual Meeting
Toripalimab combined with gemcitabine and S-1 in the first-line treatment of advanced biliary tract cancer.
First Author: Wei Li
Poster
2018 Gastrointestinal Cancers Symposium
Clinical benefit of maintenance therapy for patients with advanced biliary tract cancer without progression on first-line gemcitabine plus cisplatin.
First Author: Jaewon Hyung
First Author: Nicha Wongjarupong